American Vanguard Tops in 4Q - Analyst Blog
07 März 2013 - 9:40AM
Zacks
Specialty chemicals maker
American Vanguard Corp. (AVD) witnessed a healthy
rise in its fourth-quarter 2012 profit on the back of continued
strong market demand for its products.
The Newport Beach, Calif.-based company raked in earnings of 39
cents a share in the quarter, which beat the Zacks Consensus
Estimate by 4 cents and exceeded the year-ago quarter’s earnings of
23 cents.
Profit soared roughly 77% year over year to $11.3 million in the
quarter, buoyed by healthy demand of American Vanguard's crop
protection products. American Vanguard is leveraging the growing
demand for soil insecticides as the U.S. corn growers contend with
pest problems.
For full-year 2012, earnings climbed to $1.28 per share from 79
cents per share in 2011, also topping the Zacks Consensus Estimate
of $1.22.
Revenues climbed 28% year over year to $104.3 million in the
reported quarter, beating the Zacks Consensus Estimate of $101
million.
For the full year, revenues jumped 22% year over year to $366.2
million, backed by strong traction of American Vanguard’s Yield
Enhancing Solutions (YES). Sales beat the Zacks Consensus Estimate
of $363 million.
Gross margin rose to 44% in 2012 from 41% a year ago. Operating
expenses for the year climbed 22% year over year to $101.8 million.
Operating margin rose to 16.2% in 2012 from 13% in 2011 as a
healthy increase in revenues more than offset higher operating
costs.
American Vanguard exited 2012 with cash of $38.5 million, up
roughly 10% year over year. Total long-term debt increased 39% year
over year to $130 million. Operating cash flow for the year rose
roughly 3% year over year to $40.4 million.
American Vanguard is optimistic about 2013 and feels that it is
well placed to meet the increasing demand for soil insecticides by
maintaining full production of its products and proprietary
equipment systems. The successful roll out of its herbicide
co-marketing program with Monsanto (MON) is also
expected to support its results.
American Vanguard makes specialty chemical products for
agricultural and commercial applications. The company develops and
markets an array of chemicals, including insecticides, fungicides
and herbicides, for crops, human and animal health protection.
American Vanguard has the largest assortment of corn soil
insecticides coupled with the most advanced dispensing
equipment.
American Vanguard currently carries a Zacks Rank #3 (Hold).
Other companies in the specialty chemicals industry with a
favorable Zacks Rank are Novozymes A/S (NVZMY) and
Penford Corporation (PENX). Both hold a Zacks Rank
#1 (Strong Buy).
AMER VANGUARD (AVD): Free Stock Analysis Report
MONSANTO CO-NEW (MON): Free Stock Analysis Report
NOVOZYMES A/S (NVZMY): Get Free Report
PENFORD CORP (PENX): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
Novenesis AS (PK) (USOTC:NVZMY)
Historical Stock Chart
Von Okt 2024 bis Nov 2024
Novenesis AS (PK) (USOTC:NVZMY)
Historical Stock Chart
Von Nov 2023 bis Nov 2024
Echtzeit-Nachrichten über Novenesis AS (PK) (OTCMarkets): 0 Nachrichtenartikel
Weitere Novozymes A/s (PC) News-Artikel